Micro L8

Medical Virology & Mycology

  • Instructor: Kamyar Motavaze, Ph.D.

  • Institution: Oxford College

Key Terms

  • Verrucous carcinoma

  • Herpetic whitlow

  • Gingivostomatitis

  • Glandular fever

  • Hairy leukoplakia

  • Avian flu

  • Koplik’s spots

  • Poliomyelitis

  • HFM disease

  • German measles

  • Dermatophytosis

  • Thrush

Papovaviruses

  • Human Papillomavirus (HPV)

    • Causative agent of skin warts (verrucae), oral squamous papillomas, and verrucous carcinoma.

    • **Infections: **

      • Skin Warts:

        • Benign epithelial tumors transmissible via direct contact.

        • Less common in adults.

        • Anogenital warts caused by specific HPV serotypes, identifiable in cervical biopsies.

      • Oral Squamous Papillomas and Warts:

        • Small, exophytic, pedunculated lesions occurring between ages 30-50 years, more common in men.

      • Verrucous Carcinoma:

        • Associated with HPV-16, 18, and 33 causing cervical cancer.

        • Certain serotypes cause vulvar cancer and lymphoma.

        • Epidermodysplasia verruciformis is a type of malignant wart.

Adenoviruses

  • Causative agents of latent infections in lymphoid tissues (e.g., tonsils).

  • Infections:

    • Acute Respiratory Disease: influenza-like infection causing pharyngitis and conjunctivitis.

    • Febrile Pharyngoconjunctivitis.

    • Keratoconjunctivitis.

    • Pneumonia.

    • Gastroenteritis.

  • Transmission: Via respiratory and ocular secretions (e.g., swimming pools).

Herpesviruses

  • Types: 8 different types (HHV-1 to HHV-8).

  • Herpes Simplex Virus (HSV) [HHV-1&2]:

    • Infections:

      • Primary Infections:

        • Gingivostomatitis: affects lips/mouth.

        • Genital herpes: mostly HSV-2.

        • Encephalitis.

        • Conjunctivitis and keratitis which may lead to blindness.

        • Herpetic whitlow: finger infection from saliva.

      • Recurrent Infections:

        • Reactivation occurs (primarily in trigeminal ganglia).

        • Reactivation triggers include: stress, sunlight, febrile infection, local trauma, and menstruation.

        • HSV-1 vs HSV-2:

          • HSV-1: Above the belt via direct contact.

          • HSV-2: Below the belt via sexual contact.

        • Antivirals in prodromal phase: aciclovir, penciclovir, vidarabine.

Varicella-Zoster Virus (VZV) [HHV-3]

  • Infections:

    • Chickenpox:

      • Mild, self-limiting disease (serious in adults).

      • 2-week incubation; symptoms: fever, papular rashes that become vesicular.

    • Shingles (Herpes zoster):

      • Reactivation in adults, causing lesions on chest wall and symptoms of fever/malaise.

      • Vesicular rashes are unilateral and painful; may lead to post-herpetic neuralgia.

  • Complications:

    • Ophthalmic nerve involvement can cause eye lesions and blindness.

    • Ramsay Hunt syndrome leads to facial palsy and lesions in the auditory canal.

    • Triggering factors for shingles include immunosuppression and trauma.

    • The disease is transmissible through direct contact.

    • Treatment: systemic vidarabine and aciclovir.

    • Vaccines available for prevention.

Epstein-Barr Virus (EBV) [HHV-4]

  • Latency: Primarily in B cells.

  • Infections:

    • Glandular Fever (Infectious Mononucleosis):

      • 4-7 week incubation; affects lymphoid tissues, especially in teenagers; transmitted via saliva (known as kissing disease).

      • Symptoms: fever, lymphadenopathy, lymphocytosis, tonsillitis, splenomegaly.

  • Associated Conditions:

    • Burkitt's Lymphoma: Severe malignant tumor in African children.

    • Nasopharyngeal Carcinoma: Highly malignant tumor in Southern China.

    • Hairy Leukoplakia: Infection causing white lesions on the tongue.

Cytomegalovirus (CMV) [HHV-5]

  • Types of Infections:

    • Asymptomatic Infection: Occurs in infants; congenital infections can result in deafness/mental retardation.

    • Postnatal Infection: Severe multiorgan failure linked to pregnancy and immunosuppression.

    • Common in Patients: AIDS, transplant, and neoplasia patients.

Human Herpesvirus 6 [HHV-6]

  • Blooms in B and T cells, particularly in immunocompromised patients.

  • Infections:

    • Mononucleosis: Febrile disease in adults with cervical lymphadenopathy.

    • Exanthem subitum (Roseola infantum): Febrile disease in children causing a facial rash.

    • Strains cause erythematous papules in the oral cavity (Nagayama’s spots).

Orthomyxoviruses

  • Types: Based on nucleocapsid protein (NP) and matrix protein (M).

  • Infections:

    • Influenza: Symptoms include fever, myalgia, sore throat, cough; serious complications include pneumonia.

    • Avian Influenza: Symptoms are similar, with a potential for pneumonia and encephalitis.

    • Treatment: Amantadine and rimantadine for influenza; Tamiflu for bird flu.

Paramyxoviruses

  • Parainfluenza Virus: Causes croup, bronchiolitis, pneumonia in children, and common cold in adults.

  • Mumps Virus: Causes parotitis (mumps); preventable by MMR vaccine.

Measles Virus

  • Symptoms: Fever, headache, nasal discharge, conjunctivitis, sore throat, Koplik's spots, and rash.

  • Complications: Gangrenous stomatitis, SSPE, bronchopneumonia.

  • Prevention: Live attenuated vaccine (MMR).

Picornaviruses

  • Enteroviruses: Includes polioviruses, coxsackieviruses, rhinoviruses.

  • Poliovirus: Causative agent of paralytic poliomyelitis, transmissible through contaminated water and direct contact.

  • Prevention: Killed vaccine (Salk) or live attenuated vaccine (Sabin).

Coxsackieviruses

  • Groups A and B:

    • Coxsackievirus A: Herpangina and Hand, Foot, and Mouth Disease (common in children).

    • Symptoms: sore throat, headache, malaise, tender parotid duct pain.

Rhinoviruses

  • Common Cold: Transmitted via respiratory droplets.

Togaviruses

  • Rubella Virus (German Measles): Transmitted via respiratory secretions; causes congenital rubella syndrome.

  • Prevention: MMR vaccine.

Coronaviruses

  • Identification: Named for crown-like spikes (“crown” in Latin) on envelope.

  • Seven Human-Infecting Coronaviruses: e.g., SARS-CoV-2 (COVID-19).

Disease Impact**

  • COVID-19: First reported in December 2019 in China; WHO declared a pandemic in March 2020.

    • Such symptoms may include dry cough, fever, and loss of taste/smell; severe cases may lead to respiratory distress.

    • Treatment: Remdesivir for severe cases; supportive care recommended.

    • Prevention: Vaccines (e.g., mRNA, viral vector-based).

Oral Mycology**

  • Fungi Classification:

    • Molds: Filamentous fungi with hyphae structure.

    • Yeasts: Unicellular fungi; reproduce by budding (Candida albicans notable).

    • Dimorphic Fungi: Exist in two forms, molds in cultures and yeasts in tissues.

Human Mycoses**

  • Superficial Mycoses: Infections of keratinized tissues and mucosae (ringworm, thrush).

  • Subcutaneous Mycoses: Infections due to trauma, e.g., sporotrichosis, mycetoma.

  • Systemic Mycoses: Fungal infections of internal organs from opportunistic organisms: coccidioidomycosis, blastomycosis, histoplasmosis.

    • Increasingly concerning for immunocompromised patients.

Candida Albicans**

  • Major pathogenic yeast: can lead to superficial, mucosal, and systemic candidiasis.

    • Predisposing Factors: Chronic diseases, immunological disorders, malnutrition, age, smoking.

  • Clinical Manifestations: Thrush, candidal vulvovaginitis, skin infections, and systemic infections resume.

Cryptococcus neoformans**

  • Infection: Leading cause of cryptococcal meningitis; transmitted via respiratory droplets. Treatment: Amphotericin and fluconazole.

Filamentous and Dimorphic Fungi**

  • Relevant to dentistry: Blastomyces dermatitidis, Histoplasma capsulatum, Coccidioides immitis; transmitted via the respiratory tract.

    • Lesions generally found in the lungs or occasionally skin and oral mucosa.

    • Treatment: Amphotericin and itraconazole.

References**

  • Samaranayake L. (2024). Essential Microbiology for Dentistry. (6th edition). Churchill Livingstone Inc., London, United Kingdom. 424 p.

  • evolve.elsevier.com

robot